Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Donald Notman – Chief Financial Officer Antony Mattessich – President and Chief Executive Officer Rabia Ozden – Chief […]
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Melanie Solomon – IR Ming Hsieh – CEO Paul Kim – CFO Brandon Perthuis – Chief Commercial Officer […]
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Melanie Solomon – IR Ming Hsieh – CEO Paul Kim – CFO Brandon Perthuis – Chief Commercial Officer […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.